Market Research Logo

South Korea Pharmaceuticals & Healthcare Q1 2019

South Korea Pharmaceuticals & Healthcare Q1 2019

Key View:

South Korea will remain a prominent player in the global energy market befitting its status as a significant importer ofcrude oil and net exporter of refined fuels. The awarding of US waivers in November will allow South Korea to continue importingfrom Iran for 180 days, though political and operational considerations are likely to incentivise diversification to alternative suppliers.LNG imports will continue to flourish under the government’s pro-gas and renewables policies, although outlook beyond PresidentMoon Jae-in’s five-year term remains far less certain.


Key View
SWOT
Industry Trend Analysis
Pharmaceutical Market
Healthcare Market
Prescription Drug Market
Patented Drug Market
Generic Drug Market
OTC Medicine Market
Pharmaceutical Trade
Industry Risk/Reward Index
Asia Pacific Innovative Pharmaceuticals Risk/Reward Index
South Korea Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Daewoong Pharmaceutical
Dong-A Pharmaceutical
Eli Lilly
GlaxoSmithKline
Hanmi Pharmaceutical
MSD
Novartis
Pfizer
Sanofi-Aventis Korea
Yuhan Corporation
South Korea Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report